EpCAM-targeting CAR-T cell immunotherapy is safe and efficacious for epithelial tumors.
Li D, Guo X, Yang K, Yang Y, Zhou W, Huang Y, Liang X, Su J, Jiang L, Li J, Fu M, He H, Yang J, Shi H, Yang H, Tong A, Chen N, Hu J, Xu Q, Wei YQ, Wang W.
Li D, et al. Among authors: he h.
Sci Adv. 2023 Dec;9(48):eadg9721. doi: 10.1126/sciadv.adg9721. Epub 2023 Dec 1.
Sci Adv. 2023.
PMID: 38039357
Free PMC article.